Congress creates health care advisory panel—but industry gets a seat at the table
S. 1911 — HEALTH Panel Act · Filed by Pete Ricketts (R-NE) · 1 cosponsor · Introduced May 22, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a 15-member Panel of Health Advisors within the Congressional Budget Office to provide technical expertise and recommendations on health care policy analysis, cost estimates, and economic modeling. The panel will be appointed by House and Senate budget committee leaders and the CBO director, meet annually, and publish reports on how their recommendations are used in official CBO health care analyses.
Why we flagged it
The bill's core function is to establish an advisory panel that strengthens the Congressional Budget Office's capacity to analyze health care policy. It is a governance and transparency measure, not a substantive health policy change.
What the text implies
- Panel composition (15 members with staggered 3-year terms) may create institutional inertia; turnover is slow, potentially limiting responsiveness to new health care challenges or shifting political priorities.
- Membership qualifications explicitly include 'investment in health care companies' — this may create perception of industry influence on CBO health care scoring, even if conflict-of-interest disclosures are required.
The full analysis lists 4 implications of this text.
Who stands to gain
health insurance companies; pharmaceutical companies; health care facility operators